Anti-Snoring Aid Recall 2022: Microbial Contamination Could Be Life-Threatening For Some

Green Pharmaceuticals has issued a recall for its SnoreStop NasoSpray due to possible microbial contamination.

SnoreStop NasoSpray is used as an anti-snoring aid that can temporarily stop or reduce symptoms of non-apneic snoring. According to the recall notice, the anti-snoring aid may contain microbial contamination known as Providencia rettgeri.

While Providencia rettgeri is rarely associated with illnesses in humans, it can be severe or life-threatening in those individuals who are immunocompromised.

Providencia rettgeri can cause bacteremia/sepsis, pneumonia, invasive fungal rhinosinusitis, or disseminated fungal infection, according to the Federal Drug Administration.

The affected SnoreStop NasoSpray was sold in 0.3 fluid ounce bottles (9 ML) with a single plastic bottle with a nasal pump as a delivery system. The product also has a clear transparent plastic box that is labeled as SnoreStop NasoSpray.

It has a lot code of 2373/21222. The first part of the lot code (2373) is located on a sticker at the bottom of the bottle, and the second part of the lot code (21222) is on a sticker on the outer packaging.

The recalled anti-snoring aid was sold nationwide in health food stores and online. Consumers are urged to stop using the SnoreStop NasoSpray and return it to the place of purchase.

Questions about the recall can be directed to Green Pharmaceuticals at 1-805-388-0600, Monday through Friday from 8 a.m. to 5 p.m. PST, or by email at mail@snorestop.com.

The FDA identified the contamination in the SnoreStop NasoSpray. Green Pharmaceuticals said it has not received any reports of adverse reactions related to the recall to date.

Consumers who have problems related to using the product are encouraged to see their healthcare provider.